The CCR9-CCL25 Axis Mediates Melanoma Metastasis to the Small Intestine
Overview
Authors
Affiliations
Stemming Tumoral Growth: A Matter of Grotesque Organogenesis.
Merino M, Garcia-Sanz J Cells. 2023; 12(6).
PMID: 36980213 PMC: 10047265. DOI: 10.3390/cells12060872.
Therapeutic potential of an anti-CCR9 mAb evidenced in xenografts of human CCR9 tumors.
Santamaria S, Delgado M, Botas M, Castellano E, Corraliza-Gorjon I, Lafuente P Front Immunol. 2022; 13:825635.
PMID: 35967322 PMC: 9363564. DOI: 10.3389/fimmu.2022.825635.
Combination of PET and CXCR4-Targeted Peptide Molecule Agents for Noninvasive Tumor Monitoring.
Lin Y, Lin Y, Lin X, Sun X, Luo K J Cancer. 2019; 10(15):3420-3426.
PMID: 31293645 PMC: 6603417. DOI: 10.7150/jca.31087.
92R Monoclonal Antibody Inhibits Human CCR9 Leukemia Cells Growth in NSG Mice Xenografts.
Somovilla-Crespo B, Martin Monzon M, Vela M, Corraliza-Gorjon I, Santamaria S, Garcia-Sanz J Front Immunol. 2018; 9:77.
PMID: 29434597 PMC: 5797297. DOI: 10.3389/fimmu.2018.00077.
Deng X, Tu Z, Xiong M, Tembo K, Zhou L, Liu P Oncotarget. 2017; 8(24):39033-39047.
PMID: 28380463 PMC: 5503593. DOI: 10.18632/oncotarget.16559.